Your browser doesn't support javascript.
loading
Ofatumumab retreatment and maintenance in fludarabine-refractory chronic lymphocytic leukaemia patients.
Österborg, Anders; Wierda, William G; Mayer, Jirí; Hess, Georg; Hillmen, Peter; Schetelig, Johannes; Schuh, Anna; Smolej, Lukás; Beck, Christian; Dreyfus, Brigitte; Hellman, Andrzej; Kozlowski, Piotr; Pfreundschuh, Michael; Rizzi, Rita; Spacek, Martin; Phillips, Jennifer L; Gupta, Ira V; Williams, Vanessa; Jewell, Roxanne C; Nebot, Noelia; Lisby, Steen; Dyer, Martin J S.
Afiliación
  • Österborg A; Department of Haematology, Karolinska University Hospital, Stockholm, Sweden.
  • Wierda WG; The University of Texas, M.D. Anderson Cancer Center, Houston, TX, USA.
  • Mayer J; Cancer Therapy Research Center, San Antonio, TX, USA.
  • Hess G; Department of Internal Medicine/Haemato-Oncology, Faculty Hospital Brno, Brno, Czech Republic.
  • Hillmen P; Johannes-Gutenberg-Universtitaer Mainz, Mainz, Germany.
  • Schetelig J; Leeds Teaching Hospital, Leeds, UK.
  • Schuh A; Univesitatetsklinickum Carl Gustav Carus, Dresden, Germany.
  • Smolej L; Churchill Hospital, Oxford, UK.
  • Beck C; Faculty of Medicine in Hradec Kralove, University Hospital and Charles University in Prague, Hradec Kralove, Czech Republic.
  • Dreyfus B; Haematologisch-Onkologisches Institut, Moenchengladbach-Rheydt, Germany.
  • Hellman A; Hopital Jean Bernanrd, Poitiers, France.
  • Kozlowski P; Akademia Medyczna w Gdansku, Gdansk, Poland.
  • Pfreundschuh M; Universitetssjukhuset, Orebro, Sweden.
  • Rizzi R; Universitaesklinikum des Saarlandes, Homburg, Germany.
  • Spacek M; Azienda Ospendaliero Universitaria Policlinico Consorziale, Bari, Italy.
  • Phillips JL; Fakultni nemocnice, Praha10, Czech Republic.
  • Gupta IV; GlaxoSmithKline, Collegeville, PA, USA.
  • Williams V; GlaxoSmithKline, Collegeville, PA, USA.
  • Jewell RC; GlaxoSmithKline, Research Triangle Park, NC, USA.
  • Nebot N; GlaxoSmithKline, Research Triangle Park, NC, USA.
  • Lisby S; GlaxoSmithKline, Research Triangle Park, NC, USA.
  • Dyer MJ; Genmab, AS, Copenhagen, Denmark.
Br J Haematol ; 170(1): 40-9, 2015 Jul.
Article en En | MEDLINE | ID: mdl-25825041
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vidarabina / Leucemia Linfocítica Crónica de Células B / Anticuerpos Monoclonales / Antineoplásicos Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2015 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Vidarabina / Leucemia Linfocítica Crónica de Células B / Anticuerpos Monoclonales / Antineoplásicos Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Br J Haematol Año: 2015 Tipo del documento: Article País de afiliación: Suecia